Country
Contract Development & Manufacturing Organizations in China
Scaled API and increasingly sophisticated biologics. Compare Chinese CDMOs across API synthesis, biologics, and small molecules — by capability, certification, and site.
271 companies listed
Manufacturing sites in China
The Chinese CDMO landscape
China is one of the two dominant API-manufacturing nations and has invested heavily in moving up the value chain into biologics, cell therapy, and integrated discovery-through-manufacture services. Its largest players operate at a scale and speed that few markets can match, with rapidly improving quality infrastructure.
Manufacturing is concentrated around the Yangtze River Delta (Shanghai, Suzhou, Wuxi), the Pearl River Delta, and Beijing–Tianjin. These hubs combine large-scale chemistry, growing biologics capacity, and dense supplier ecosystems for intermediates and raw materials.
The BIOSECURE Act has made China the central variable in global outsourcing strategy. While pharmaceutical products are not banned, sponsors — especially those touching US government funding — are actively de-risking by qualifying second sources in India, Europe, and the US. China remains a major global player, but supply-chain dual-sourcing is now the prevailing strategy.
Companies (60)
Accela ChemBio
China
A
Acebright Group
China
Acro Biosystems
China
A
Advanced Therapies
China
Airkey Envirotech Co. Ltd.
China
A
Ajay Europe Sarl (Ajay‑SQM)
China
A
Allsino Pharmaceutical Co., Ltd.
China
Altruist Biologics
China
AmbioPharm
China
A
Anhui Biochem Pharmaceutical Co.,Ltd
China
A
Anhui Chengshi Pharmaceutical Co.,Ltd
China
A
Anhui Qingyun Pharmaceutical and Chemical Co., Ltd.
China
Anhui Royal Chemical Co.,Ltd
China
Anhui Sunhere Pharmaceutical Excipients Co., Ltd.
China
Apeloa Pharmaceutical
China
A
AptarGroup Inc
China
Arkema
China
Arvato (Healthcare)
China
Arxada (CDMO)
China
A
Ash-LongChem Technology Limited
China
A
AsiaPharma Corp.
China
A
AstaTech (Chengdu) BioPharmaceutical Corp.
China
AsymBio (Asymchem Group)
China
Asymchem
China
Aton Biotech
China
A
Aurisco Pharmaceutical
China
AUSTAR Equipment Ltd (AUSTAR Group)
China
Autajon Group (Pharmaceuticals)
China
B
Baumann Medical AG
China
B
Bausch+Ströbel SE + Co. KG
China
Baxter International
China
BBI Solutions
China
B
Beijing Odyssey Chemicals Co., Ltd.
China
B
Beijing Sunho Pharmaceutical Co., Ltd
China
B
Berry Global
China
BioDuro (BioDuro-Sundia)
China
Biofarma S.p.A. (Biofarma Group)
China
BiOligo Biotechnology (Shanghai) Co., Ltd.
China
bioMérieux (Industry division)
China
Biopharma Group CDMO
China
B
Biosynth
China
Biotage AB
China
B
Birdo (Shanghai) Pharmatech Co., Ltd. (BirdoTech)
China
BLi-T (Hefei) Chemical Co., Ltd.
China
Blue Yonder
China
Boehringer Ingelheim Biopharmaceuticals GmbH (BioXcellence)
China
B
Bright Chemicals (brightchemicals.com)
China
C‑Ray Therapeutics
China
C
Canaan Technology Group (Zhejiang Canaan Technology Co., Ltd.)
China
Canton Biologics Co., Ltd.
China
Capot Chemical Co., Ltd.
China
CARBOGEN AMCIS
China
C
Cardinal Health (Clinical Supply Services)
China
Catalent Pharma Solution
China
CATUG (CATUG Biotech)
China
CCL Healthcare
China
C
CD BioGlyco
China
Celanese
China
Changsha Huir Biological-tech Co., Ltd
China
Changzhou Comwin Fine Chemicals Co., Ltd
China
Frequently Asked Questions
How many CDMOs are in China?+
CDMO Hub lists a large China roster — the live count and ranked list above are derived from verified manufacturing sites, reflecting genuine production footprint in the country.
How does the BIOSECURE Act affect using a Chinese CDMO?+
The BIOSECURE Act targets specific foreign biotech firms of concern and primarily restricts US government-funded programs. It has not banned Chinese pharmaceutical manufacturing broadly, but it has driven sponsors to qualify alternative sources and dual-source critical supply — a risk-management response rather than an outright exit.
What modalities are Chinese CDMOs strongest in?+
China is strongest in large-scale API and intermediate synthesis and small-molecule manufacturing, with rapidly expanding biologics, ADC, and cell-therapy capacity. Quality infrastructure has improved markedly, though facility-level due diligence remains essential.
Are Chinese CDMOs FDA-inspected?+
Many Chinese CDMOs hold FDA and EU GMP approvals for export products and are subject to FDA inspection. As always, approvals are facility- and product-specific — verify the relevant site's inspection history for your target market and modality.
Find the right CDMO in China
Our AI Matchmaker analyzes your project requirements and matches you with qualified China manufacturing partners. Free for buyers.